3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Carcinoma, Non-Small-Cell Lung
9
Rhabdomyosarcoma
6
Triple Negative Breast Neoplasms
5
Hodgkin Disease
4
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Adenocarcinoma
2
Solitary Fibrous Tumor, Pleural
1
NSCLC
1
Metastatic HER2-positive Breast Cancer
1
Mesothelioma, Malignant
1
Lung Diseases, Interstitial
1
Locally Advanced Non-Small Cell Lung Cancer
1
HR+HER2- Breast Cancer
1
Fludzoparib" and Anti-angiogenic
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Large Cell
1
Advanced Breast Cancer
1
Interventions
Cyclophosphamide
9
Biopsy
5
Specimen Handling
4
Prednisone
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
fludarabine
3
Vincristine
3
Etoposide
3
Doxorubicin
3
Brentuximab Vedotin
3
sodium-iodide symporter
2
pembrolizumab
2
fludarabine phosphate
2
cemiplimab
2
alectinib
2
X-Rays
2
Whole-Body Irradiation
2
Stem Cell Transplantation
2
Rituximab
2
Positron-Emission Tomography
2
Photons
2
Mycophenolic Acid
2
Immunoglobulin G
2
Filgrastim
2
Disulfides
2
Cyclosporine
2
10-propargyl-10-deazaaminopterin
2
treosulfan
1
talimogene laherparepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Anaplastic
×
Vinorelbine
×
1 year
×
Clear all
No trials found.